Move for more Medicare off-label cancer drugs creates contention

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.572, 2009-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hospital Supply of Off‐label Immunomodulatory Drugs

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 39, Iss. 2, 2009-06 ,pp. : 135-139

John Wiley & Sons Inc

Access to resources Recommend Favorite

Written Consent to Use the Drug in Children: The Problem of Off-Label Drugs

Current Pharmaceutical Design, Vol. 14, Iss. 8, 2008-03 ,pp. : 776-781

Bentham Science Publishers

Access to resources Recommend Favorite

Changes needed to make off-label prescribing more appropriate

Inpharma, Vol. 1, Iss. 1578, 2007-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Changes needed to make off-label prescribing more appropriate

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 523, 2007-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Off-Label Pharmacovigilance

By Edwards I. Ralph

Drug Safety, Vol. 34, Iss. 10, 2011-10 ,pp. : 795-797

Adis International

Access to resources Recommend Favorite